|
End-of-day quote
Thailand S.E.
2026-10-06
|
5-day change | 1st Jan Change | ||
| 33.50 THB | 0.00% |
|
-2.90% | - |
| Market Cap | 29.21B 867M 775M 723M 657M 1.24B 83.91B 1.25B 8.69B 3.39B 42.67B 3.26B 3.19B 137B | P/E 2026 * |
12.8x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 24.59B 730M 653M 609M 553M 1.04B 70.65B 1.05B 7.32B 2.86B 35.93B 2.74B 2.68B 116B | EV / Sales 2026 * |
1.72x | EV / Sales 2027 * | 1.58x |
| Free-Float |
38.66% | Yield 2026 * |
5.32% | Yield 2027 * | 5.7% |
Last Transcript: Mega Lifesciences
| 1 week | -2.90% | ||
| Current month | -0.74% | ||
| 1 month | -6.94% | ||
| 3 months | -11.84% | ||
| 6 months | +0.75% |
| 1 week | 33 |  | 34.25 |
| 1 month | 33 | | 36.75 |
| Current year | 31.5 | | 40 |
| 1 year | 27.75 | | 40 |
| 3 years | 24.3 | | 46.25 |
| 5 years | 24.3 | | 56.5 |
| 10 years | 17.9 | | 56.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vivek Dhawan
CEO | Chief Executive Officer | 64 | 1987-12-31 |
Thomas Abraham
DFI | Director of Finance/CFO | 62 | 1996-12-31 |
Jonnara Reddy
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Abraham
BRD | Director/Board Member | 62 | 1997-12-31 |
Vivek Dhawan
BRD | Director/Board Member | 64 | 2012-12-31 |
Thor Santhisiri
BRD | Director/Board Member | 73 | 2013-01-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.90% | - | - | 869M | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,032B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 614B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 471B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 350B | |
| +2.92% | +3.12% | +24.78% | +45.10% | 337B | |
| +2.42% | +0.05% | +14.13% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 218B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 179B | |
| Average | +1.31% | -1.16% | +28.56% | +59.87% | 412.76B | |
| Weighted average by Cap. | +0.81% | -0.47% | +32.01% | +70.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.33B 426M 380M 355M 322M 607M 41.17B 611M 4.26B 1.67B 20.94B 1.6B 1.56B 67.31B | 15.5B 460M 411M 384M 349M 656M 44.53B 661M 4.61B 1.8B 22.65B 1.73B 1.69B 72.8B |
| Net income | 2.24B 66.61M 59.52M 55.53M 50.44M 94.99M 6.44B 95.7M 667M 261M 3.28B 250M 245M 10.54B | 2.49B 73.83M 65.96M 61.54M 55.9M 105M 7.14B 106M 740M 289M 3.63B 277M 271M 11.68B |
| Net Debt | -4.62B -137M -123M -114M -104M -196M -13.26B -197M -1.37B -537M -6.75B -515M -504M -21.68B | -4.72B -140M -125M -117M -106M -200M -13.56B -201M -1.4B -549M -6.9B -526M -515M -22.17B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | THB 33.50 | 0.00% | 191,600 |
| 26-10-06 | THB 33.50 | 0.00% | 842,800 |
| 26-10-05 | THB 33.50 | -0.74% | 276,700 |
| 26-10-02 | THB 33.75 | -0.74% | 155,600 |
| 26-10-01 | THB 34.00 | +0.74% | 440,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEGA Stock
- MEGA-R Stock
Select your edition
All financial news and data tailored to specific country editions
